NCT00332059已完成3 期
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 445
- 试验地点
- 4
- 主要终点
- IOP
研究概览
简要总结
The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of glaucoma or ocular hypertension in both eyes
- •Patient requires IOP-lowering drug in both eyes
排除标准
- •Uncontrolled medical conditions
- •Contraindication to beta-adrenoceptor antagonist therapy
结局指标
主要结局
IOP
次要结局
未报告次要终点
研究者
研究点 (4)
Loading locations...
相似试验
已完成
3 期
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular HypertensionOcular HypertensionNCT00332072Allergan541
已完成
3 期
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionOcular HypertensionNCT00332540Allergan520
已完成
4 期
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been TreatedGlaucoma, Open-AngleNCT01243567Allergan81
已完成
2 期
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic AlopeciaAlopecia, AndrogeneticBaldnessAlopeciaNCT01325337Allergan307
已完成
2 期
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair LossBaldnessAlopeciaNCT01325350Allergan306